Holen Sie sich die Stockscreener-App
0.40
4.08%
-0.017
Vorhandelsmarkt:
.40
Schlusskurs vom Vortag:
$0.417
Offen:
$0.4112
24-Stunden-Volumen:
450.69K
Relative Volume:
1.52
Marktkapitalisierung:
$8.20M
Einnahmen:
$2.82M
Nettoeinkommen (Verlust:
$-14.20M
KGV:
-0.4706
EPS:
-0.85
Netto-Cashflow:
$-15.13M
1W Leistung:
-8.55%
1M Leistung:
-12.18%
6M Leistung:
-44.03%
1J Leistung:
-54.01%
1-Tages-Spanne:
$0.397
$0.439
1-Wochen-Bereich:
$0.3842
$0.4488
52-Wochen-Spanne:
$0.38
$1.19
Talphera Inc Stock (TLPH) Company Profile
Firmenname
Talphera Inc
Sektor
Telefon
650-216-3500
Adresse
1850 GATEWAY DRIVE, SAN MATEO
Vergleichen Sie TLPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TLPH
Talphera Inc
|
0.40 | 8.97M | 2.82M | -14.20M | -15.13M | -0.85 |
|
ZTS
Zoetis Inc
|
151.19 | 68.05B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.55 | 46.58B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.65 | 43.71B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.29 | 18.40B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
297.89 | 13.23B | 2.99B | 1.21B | 1.13B | 25.06 |
Talphera Inc Stock (TLPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-28 | Eingeleitet | Rodman & Renshaw | Buy |
| 2020-07-20 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2019-11-11 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2019-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2019-07-10 | Fortgesetzt | Credit Suisse | Outperform |
| 2019-04-24 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-02-15 | Eingeleitet | Credit Suisse | Outperform |
| 2018-10-23 | Eingeleitet | B. Riley FBR | Buy |
| 2017-10-13 | Herabstufung | Jefferies | Buy → Hold |
| 2017-10-13 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-07-14 | Fortgesetzt | Jefferies | Buy |
| 2016-09-15 | Bestätigt | ROTH Capital | Buy |
| 2016-08-05 | Herabstufung | Stifel | Buy → Hold |
| 2015-10-30 | Hochstufung | Jefferies | Hold → Buy |
| 2015-10-05 | Bestätigt | ROTH Capital | Buy |
| 2015-09-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2015-07-10 | Fortgesetzt | ROTH Capital | Buy |
| 2015-05-06 | Bestätigt | Mizuho | Neutral |
| 2015-05-05 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-03-10 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-03-09 | Herabstufung | Mizuho | Buy → Neutral |
Alle ansehen
Talphera Inc Aktie (TLPH) Neueste Nachrichten
What analysts say about Talphera Inc. stockRecord-breaking capital gains - jammulinksnews.com
What makes Talphera Inc. stock price move sharplyFree Step-by-Step Investment Guide - Newser
Is Talphera Inc. a good long term investmentLightning-fast growth - jammulinksnews.com
What drives Talphera Inc. stock priceAccelerated investment success - Autocar Professional
Talphera Inc. Stock Analysis and ForecastExplosive wealth accumulation - Autocar Professional
How high can Talphera Inc. stock price go in 2025Free Stock Tips Group - Newser
what makes talphera inc. stock price move sharplyCapital Growth Picks - Newser
Why Talphera Inc. stock attracts strong analyst attentionSafe and Scalable Investment Tips - Newser
How Talphera Inc. stock performs during market volatilityFree Stock Market Strategy Classes - Newser
TLPH’s Stock Dilemma: Talphera Inc’s Market Performance and Outlook - investchronicle.com
Talphera Stock Plunges 15.61% on Earnings, FDA News - AInvest
Talphera, Inc. (NASDAQ:TLPH) Q1 2025 Earnings Call Transcript - MSN
talphera receives extension to meet nasdaq listing requirements - Investing.com India
talphera receives extension to meet nasdaq listing requirements By Investing.com - Investing.com South Africa
Talphera Granted Extension for Nasdaq Compliance - TipRanks
Financial Review: Talphera (NASDAQ:TLPH) & Alterity Therapeutics (NASDAQ:ATHE) - Defense World
Talphera’s Strategic Advancements and Financial Stability Reinforce Buy Rating - TipRanks
Talphera outlines accelerated NEPHRO CRRT study timeline with completion targeted by end of 2025, supported by new site activations and $14.8M financing - MSN
Talphera, Inc. Earnings Call: Strategic Adjustments and Financial Progress - TipRanks
TLPH Prepares to Finalize NEPHRO CRRT Registration Trial | TLPH Stock News - GuruFocus
Talphera: Q1 Earnings Snapshot - Greenwich Time
Talphera Inc (TLPH) Q1 2025 Earnings Call Highlights: Strategic Cost Reductions and FDA ... - Yahoo Finance
Talphera, Inc. Reports Q1 2025 Financial Results - TipRanks
Talphera Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: Talphera Inc. outlines strategic shifts in Q1 2025 - Investing.com Nigeria
Finanzdaten der Talphera Inc-Aktie (TLPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.09%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):